TSA Medical Marijuana Policy Unchanged Despite Viral Claims
- MEDICAL MARIJUANA
- June 2, 2026
Cannabidiol is emerging as a popular option for people seeking pain relief without the intoxicating effects associated with THC. Drawing on survey data and clinical reviews, Forbes Health reports that many adults now use CBD for conditions such as arthritis, chronic pain and joint discomfort, often noting improvements in sleep and physical function. At the
READ MOREMedical marijuana in the U.S. is at a crossroads as federal officials move to shift it from the tightly restricted Schedule I category toward Schedule III, following an executive order signed by President Donald Trump in December 2025 and a process begun under President Joe Biden in 2022. This change could ease research barriers and
READ MOREEmily and Spencer, parents from Nunney near Frome, say medical cannabis has transformed the life of their six-year-old daughter, Clover, who suffers from Aicardi Syndrome. Since starting treatment in 2020, her seizures have drastically reduced—from dozens daily to just a few mild ones—though the family spends £750 a month on privately sourced cannabis oil. After
READ MOREOnce criminalized nationwide by the Marihuana Tax Act of 1937, cannabis is now legal in some form across most U.S. states, with many authorizing medical use and a growing cohort permitting recreational sales. Yet federal law still classifies marijuana as a Schedule I drug under the Controlled Substances Act, creating a clash between Washington and
READ MORECannabidiol (CBD) oil is emerging as a potential tool for managing anxiety, but experts caution that the evidence remains incomplete and uneven. Recent reviews suggest CBD may ease symptoms in conditions such as generalized and seasonal affective anxiety disorders, with clearer benefits at daily doses in the 300–400 milligram range, though responses vary widely between
READ MOREAs President Donald Trump’s 2025 executive order to reschedule cannabis moves forward, America’s $32 billion marijuana industry faces both promise and peril. The order directs the Attorney General to downgrade marijuana from a Schedule I to Schedule III substance—an administrative shift that could unlock major tax relief but still fall short of full legalization. Meanwhile,
READ MOREA new clinical trial out of Thailand suggests that cannabis-based treatments may be just as effective as lorazepam, a commonly prescribed benzodiazepine, for managing chronic insomnia. Published in Sleep Medicine, the randomized trial involved 60 adults who received either lorazepam, cannabis oil extracts, or a cannabinoid-infused herbal pill nightly for four weeks. All three groups
READ MOREHawaiʻi could soon join the growing list of states allowing recreational cannabis, as a proposed constitutional amendment by Rep. David Tarnas may put the issue before voters this November. Currently operating under a medical-only framework, dispensary owners say the state’s system no longer reflects modern realities. TY Cheng of Aloha Green Apothecary criticized lawmakers for
READ MOREAs anxiety rates climb, a growing wave of consumers is turning to CBD to take the edge off daily stress. A recent feature from the Las Vegas Optic highlights a dozen CBD options, ranging from fast-acting tinctures and oil drops to gummies, bath bombs, and high-potency nighttime formulas, all vetted for purity, potency and third-party
READ MORE